Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Blood (2023) 141 (23): 2867–2877.

https://doi.org/10.1182/blood.2022018665

Published: 2023

Includes: Supplemental data

Journal Articles

Characteristics and Outcome of Adults with Severe Autoimmune Hemolytic Anemia Admitted in Intensive Care Unit: Results from a Large French Observational Study

Clara Pouchelon, Charlotte Lafont, Antoine Lafarge, Thibault Comont, Etienne Riviere, David Boutboul, Antoine Dossier, Sylvain Audia, Julien Vaidie, Marc Ruivard, Delphine Gobert, Guillaume Bonnard, Mohamed Hamidou, Corinne Haioun, Bertrand Godeau, Marc Michel

Blood (2021) 138 (Supplement 1): 930.

https://doi.org/10.1182/blood-2021-146588

Published: 2021

Journal Articles

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Blood (2021) 138 (Supplement 1): 583.

https://doi.org/10.1182/blood-2021-152767

Published: 2021

Journal Articles

Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect

Julien Carvelli, Christelle Piperoglou, Catherine Farnarier, Frédéric Vely, Karin Mazodier, Sandra Audonnet, Patrick Nitschke, Christine Bole-Feysot, Mohamed Boucekine, Audrey Cambon, Mohamed Hamidou, Jean-Robert Harle, Geneviève de Saint Basile, Gilles Kaplanski

Blood (2020) 136 (5): 542–552.

https://doi.org/10.1182/blood.2019003664

Published: 2020

Includes: Supplemental data

Journal Articles

Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

Blood (2019) 134 (24): 2209–2217.

https://doi.org/10.1182/blood.2019000748

Published: 2019

Includes: Supplemental data

Journal Articles

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Blood (2019) 134 (Supplement_1): 840.

https://doi.org/10.1182/blood-2019-130009

Published: 2019

Journal Articles

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura

Blood (2018) 132 (20): 2143–2153.

https://doi.org/10.1182/blood-2018-04-840090

Published: 2018

Includes: Supplemental data

Journal Articles

A Multicenter Study Evaluating the Safety of Romiplostim at Maximal Dosage for Emergency Bleeding Situations in Immune Thrombocytopenia

Mathilde Roumier, MD, Louis Terriou, MD, Mohamed Hamidou, MD PhD, Antoine Dossier, MD, Anne Sophie Morin, MD, Virginie Zarrouk, MD, Mickael Ebbo, MD, Guillaume Moulis, MD PhD, Lionel Galicier, MD, Sylvain Audia, MD PhD, Laetitia Languille, Marie Goussef, MD, Solène Poutrel, MD, Marc Michel, MD, Bertrand Godeau, MD PhD, Matthieu Mahévas, MD PhD

Blood (2016) 128 (22): 2541.

https://doi.org/10.1182/blood.V128.22.2541.2541

Published: 2016

Journal Articles

Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort

Louis Terriou, MD, Zelie Guitton, MD, Miguel Hie, MD, Zahir Amoura, MD MSc, James B. Bussel, MD, Mohamed Hamidou, MD PhD, Eric Rosenthal, MD, jean-Christophe Lega, MD, Raphaele nove-Josserand, MD, Bertrand Lioger, MD, Axel Chaminade, MD, Nadine magy-Bertrand, MD PhD, Sylvain Audia, MD PhD, Matthieu Mahevas, MD PhD, Bertrand Godeau, MD PhD

Blood (2016) 128 (22): 2542.

https://doi.org/10.1182/blood.V128.22.2542.2542

Published: 2016

Journal Articles

A Multicenter, Case-Control Study Evaluating the Characteristics and Outcome of ITP Patients Refractory to, Rituximab, Splenectomy and Both TPO Receptor Agonists

Blood (2015) 126 (23): 3460.

https://doi.org/10.1182/blood.V126.23.3460.3460

Published: 2015

Journal Articles

A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults

Marc Michel, MD, Louis Terriou, MD, Françoise Roudot-Thoraval, MD PhD, Mohamed Hamidou, MD PhD, Mikael Ebbo, MD, Guillaume Le guenno, Sylvain Audia, MD PhD, Bruno Royer, MD, anne-Sophie Morin, MD, Jean Marie Michot, MD, Arnaud Jaccard, MD PhD, Laurent Frenzel, MD PhD, Corinne Haioun, MD PhD, Mehdi Khellaf, MD, Bertrand Godeau, MD PhD

Blood (2015) 126 (23): 3338.

https://doi.org/10.1182/blood.V126.23.3338.3338

Published: 2015

Journal Articles

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Blood (2015) 126 (8): 1009–1016.

https://doi.org/10.1182/blood-2014-12-614743

Published: 2015

Includes: Supplemental data

Journal Articles

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Blood (2014) 124 (21): 3254.

https://doi.org/10.1182/blood.V124.21.3254.3254

Published: 2014

Journal Articles

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Miguel Hie, Julie Gay, Lionel Galicier, François Provôt, Claire Presne, Pascale Poullin, Guy Bonmarchand, Alain Wynckel, Ygal Benhamou, Philippe Vanhille, Aude Servais, Dominique Bordessoule, Jean-Philippe Coindre, Mohamed Hamidou, Jean-Paul Vernant, Agnès Veyradier, Paul Coppo, the French Thrombotic Microangiopathies Reference Centre

Blood (2014) 124 (2): 204–210.

https://doi.org/10.1182/blood-2014-01-550244

Published: 2014

Includes: Supplemental data

Journal Articles

Chronic Infection, a Neglected Cause Of Development Of Monoclonal Gammopathy Of Undetermined Significance (MGUS) and Myeloma

Delphine Feron, PhD, Cathy Charlier, Pauline Lehebel, Denis Caillot, MD, Cedric Rossi, MD, Laurent Garderet, MD, Marianne Coste-Burel, Philippe Moreau, MD, Mohamed Hamidou, Francois Girodon, MD, PhD, Pierre Weigel, Sylvie Hermouet, MD, Ph.D., Edith Bigot-Corbel

Blood (2013) 122 (21): 3116.

https://doi.org/10.1182/blood.V122.21.3116.3116

Published: 2013

Journal Articles

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Blood (2013) 122 (21): 450.

https://doi.org/10.1182/blood.V122.21.450.450

Published: 2013

Journal Articles

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

Philippe Quittet, MD, Mohamed Hamidou, Bernard Bonnotte, M.D., Ph.D., Olivier Fain, Kerry Dillingham, Georg Kreuzbauer, MD

Blood (2012) 120 (21): 4643.

https://doi.org/10.1182/blood.V120.21.4643.4643

Published: 2012

Journal Articles

Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients

Mehdi Khellaf, Jean-François Viallard, MD, PhD, Mohamed Hamidou, Stephane Cheze, Francois Lefrere, Olivier Fain, Sylvain Audia, M.D., Ph.D., Fabrice Jardin, MD, PhD, Emmanuel Gyan, MD, PhD, jean Marc Durand, Corinne Haioun, Philippe Bierling, MD, Marc Michel, Bertrand Godeau, MD

Blood (2012) 120 (21): 4651.

https://doi.org/10.1182/blood.V120.21.4651.4651

Published: 2012

Journal Articles

Chronic Viral Infection, Virus-Specific Monoclonal Immunoglobulin, and Development of Plasma Cell Malignancy

Delphine Feron, Cathy Charlier, Victor Gourain, Marianne Coste, Philippe Moreau, MD, Mohamed Hamidou, Laurent Garderet, MD, Yannick Jacques, Pierre Weigel, Sylvie Hermouet, MD, PhD, Edith Bigot-Corbel

Blood (2011) 118 (21): 2875.

https://doi.org/10.1182/blood.V118.21.2875.2875

Published: 2011

Journal Articles

Blood CD34 − c-Kit + cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor

Sophie Georgin-Lavialle, Ludovic Lhermitte, Cédric Baude, Stéphane Barete, Julie Bruneau, Jean-Marie Launay, Marie-Olivia Chandesris, Katia Hanssens, Christian de Gennes, Gandhi Damaj, Fanny Lanternier, Mohamed Hamidou, Olivier Lortholary, Patrice Dubreuil, Frédéric Feger, Yves Lepelletier, Olivier Hermine

Blood (2011) 118 (19): 5246–5249.

https://doi.org/10.1182/blood-2011-02-335950

Published: 2011

NARROW

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Characteristics and Outcome of Adults with Severe Autoimmune Hemolytic Anemia Admitted in Intensive Care Unit: Results from a Large French Observational Study

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect

Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura

A Multicenter Study Evaluating the Safety of Romiplostim at Maximal Dosage for Emergency Bleeding Situations in Immune Thrombocytopenia

Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort

A Multicenter, Case-Control Study Evaluating the Characteristics and Outcome of ITP Patients Refractory to, Rituximab, Splenectomy and Both TPO Receptor Agonists

A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Chronic Infection, a Neglected Cause Of Development Of Monoclonal Gammopathy Of Undetermined Significance (MGUS) and Myeloma

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients

Chronic Viral Infection, Virus-Specific Monoclonal Immunoglobulin, and Development of Plasma Cell Malignancy

Blood CD34 − c-Kit + cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only